Inventor
THOM STEPHEN
GB44 patents
⚠️ This page may combine multiple inventors who share the name “THOM STEPHEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRAZENECA AB
14 patentsUS6812226B2Nov 2, 2004
P2X7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular disease
ASTRAZENECA AB33 citations92
US6518286B1Feb 11, 2003
Compounds
ASTRAZENECA AB19 citations92
US8008350B2Aug 30, 2011
Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
ASTRAZENECA AB15 citations91
US6903085B1Jun 7, 2005
Substituted piperidine compounds useful as modulators of chemokine receptor activity
ASTRAZENECA AB37 citations90
US8003703B2Aug 23, 2011
Phenoxiacetic acid derivatives
ASTRAZENECA AB9 citations84
US7125881B2Oct 24, 2006
Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives
ASTRAZENECA AB19 citations83
US6369064B1Apr 9, 2002
Triazolo(4,5-d)pyrimidine compounds
ASTRAZENECA AB20 citations83
US7709521B2May 4, 2010
Substituted indole derivatives for pharmaceutical compositions for treating respiratory diseases
ASTRAZENECA AB12 citations82
US6946478B2Sep 20, 2005
Compounds
ASTRAZENECA AB6 citations73
US8022248B2Sep 20, 2011
Substituted acids for the treatment of respiratory diseases
ASTRAZENECA AB7 citations72
US9533978B2Jan 3, 2017
Pyrimidine derivatives and their use in the treatment of cancer and further diseases
ASTRAZENECA AB2 citations68
US7605159B2Oct 20, 2009
Cathepsin cysteine protease inhibitors and their use
ASTRAZENECA AB3 citations57
US7439240B2Oct 21, 2008
Purine-or pyrrolol[2,3-d]pyrimidine-2-carbonitiles for treating diseases associated with cysteine protease activity
ASTRAZENECA AB1 citations51
US8349897B2Jan 8, 2013
Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
ASTRAZENECA AB0 citations48
INFLAZOME LTD
12 patentsUS11370776B2Jun 28, 2022
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
INFLAZOME LTD6 citations73
US11542255B2Jan 3, 2023
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
INFLAZOME LTD2 citations70
US11613542B2Mar 28, 2023
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
INFLAZOME LTD2 citations69
US11926600B2Mar 12, 2024
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
INFLAZOME LTD1 citations62
US11981667B2May 14, 2024
Sulfonamide carboxamide compounds
INFLAZOME LTD1 citations61
US11623922B2Apr 11, 2023
Compounds
INFLAZOME LTD1 citations61
US11518739B2Dec 6, 2022
Sulfonamide carboxamide compounds
INFLAZOME LTD2 citations61
US11465992B2Oct 11, 2022
Sulfonamide carboxamide compounds
INFLAZOME LTD1 citations61
US12221434B2Feb 11, 2025
Sulfonamide carboxamide compounds
INFLAZOME LTD0 citations59
US11724988B2Aug 15, 2023
Processes
INFLAZOME LTD0 citations53
US12012392B2Jun 18, 2024
Sulfonamide carboxamide compounds
INFLAZOME LTD0 citations50
US11773058B2Oct 3, 2023
Sulfonamide carboxamide compounds
INFLAZOME LTD0 citations50
BONNERT ROGER VICTOR
6 patentsUS8067413B2Nov 29, 2011
9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators
BONNERT ROGER VICTOR17 citations83
US8067411B2Nov 29, 2011
Compounds
BONNERT ROGER VICTOR11 citations81
US8436178B2May 7, 2013
Imidazoquinolines with immuno-modulating properties
BONNERT ROGER VICTOR2 citations62
US8394986B2Mar 12, 2013
Phenoxiacetic acid derivatives
BONNERT ROGER VICTOR0 citations51
US8063051B2Nov 22, 2011
9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7) modulators
BONNERT ROGER VICTOR2 citations51
US8524715B2Sep 3, 2013
Phenoxyacetic acid derivatives useful for treating respiratory diseases
BONNERT ROGER VICTOR0 citations39